+254 743 139 059
apifa@apiforafrica.org
Nairobi
Lavington,Ikigia
Monday - Friday 08h - 17h
Closed on Weekends
News
Emzor’s $23m plant to save dollars, save lives
The loan covers up to 60 percent of the project, which will initially focus on four anti-malaria APIs including artemether, lumefantrine, sulfadoxine, and pyrimethamine.
EIB Announces €14M to Emzor Pharmaceutical, Facilitated by APIFA
The partnership aims to address a long-standing challenge: the insufficient API manufacturing capacity in sub-Saharan Africa, coupled with the high cost of imported medicines
Emzor partners with Mangalam to manufacture Active Pharmaceutical Ingredients
Medical Services & Tech News
Essential API– Nigeria
The operation aims at increasing the manufacturing capacity of Active Pharmaceutical Ingredients (APIs) in Africa.
The coronavirus exposed the US’ reliance on India for generic drugs. But that supply chain is ultimately controlled by China
By Priyali Sur, CNN (May 17, 2020)
Covid-19 hastens French push to bring home medicines manufacture
By Leila Abboud and Michael Peel, Financial Times (July 29, 2020)
APIFA contributed expertise and serves a a promoter to the EIB’s EUR 50 million Africa pharmaceutical manufacturing initiative
Press Release